-+ 0.00%
-+ 0.00%
-+ 0.00%
Warner Pharmaceuticals announced that the company recently received the “Drug Registration Certificate” for tiprednone capsules approved and issued by the State Drug Administration. The drug approval number is Sinopharm's standard H20266646, the specification is 50 mg, and the registration classification is 4 types of chemicals, which is deemed to have passed the consistency evaluation. This drug is mainly used for acute gastritis, improvement of gastric mucosal lesions during acute exacerbation of chronic gastritis, and gastric ulcers. The company enjoys some of the rights in the above drugs, and obtaining its registration certificate will not have a significant impact on the company's recent performance.
Share
Listen to the news
Warner Pharmaceuticals announced that the company recently received the “Drug Registration Certificate” for tiprednone capsules approved and issued by the State Drug Administration. The drug approval number is Sinopharm's standard H20266646, the specification is 50 mg, and the registration classification is 4 types of chemicals, which is deemed to have passed the consistency evaluation. This drug is mainly used for acute gastritis, improvement of gastric mucosal lesions during acute exacerbation of chronic gastritis, and gastric ulcers. The company enjoys some of the rights in the above drugs, and obtaining its registration certificate will not have a significant impact on the company's recent performance.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending